Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $4.38 HKD
Change Today -0.07 / -1.57%
Volume 544.0K
8049 On Other Exchanges
Symbol
Exchange
Berlin
As of 4:01 AM 04/24/15 All times are local (Market data is delayed by at least 15 minutes).

jilin province huinan-h (8049) Snapshot

Open
$4.45
Previous Close
$4.45
Day High
$4.45
Day Low
$4.34
52 Week High
04/9/15 - $5.20
52 Week Low
02/13/15 - $2.65
Market Cap
2.5B
Average Volume 10 Days
576.6K
EPS TTM
$0.24
Shares Outstanding
172.5M
EX-Date
10/10/12
P/E TM
14.8x
Dividend
--
Dividend Yield
--
Current Stock Chart for JILIN PROVINCE HUINAN-H (8049)

Related News

No related news articles were found.

jilin province huinan-h (8049) Related Businessweek News

No Related Businessweek News Found

jilin province huinan-h (8049) Details

Jilin Province Huinan Changlong Bio-pharmacy Company Limited, together with its subsidiaries, primarily manufactures and distributes biochemical, Chinese, and Western medicines under the Changlong and Shendi brand names in the People’s Republic of China. Its principal products cover inter alia antibiotics and medicines for the treatment of cerebral embolism, brain and heart blood vessels related diseases, hepatitis, diabetes, prostatic diseases, pain and bleeding caused by cancer and surgery, hormone disorder, inflammation of gallbladder, gallstones, and traumatic injury. The company offers its medicines in the form of tablets, capsules, liquefied injections, powders, and granules. It is also involved in the trading of biochemical medicines. The company, formerly known as Jilin Province Huinan Biochemical Pharmaceutical Company Limited, was founded in 1989 and is based in Mongkok, Hong Kong.

550 Employees
Last Reported Date: 03/31/15
Founded in 1989

jilin province huinan-h (8049) Top Compensated Officers

Executive Chairman, General Manager, Complian...
Total Annual Compensation: CNY1.3M
Chief Finance Officer and Executive Director
Total Annual Compensation: CNY397.0K
Deputy General Manager, Executive Director an...
Total Annual Compensation: CNY605.0K
Executive Director
Total Annual Compensation: CNY411.0K
Chief Engineer and Executive Director
Total Annual Compensation: CNY404.0K
Compensation as of Fiscal Year 2013.

jilin province huinan-h (8049) Key Developments

Jilin Province Huinan Changlong Bio-Pharmacy Co. Ltd. Announces Audited Consolidated Earnings Results for the Year Ended December 31, 2014

Jilin Province Huinan Changlong Bio-Pharmacy Co. Ltd. announced audited consolidated earnings results for the year ended December 31, 2014. For the year, the company reported turnover was RMB 601,715,000 compared to RMB 457,746,000 a year ago. Profit from operations was RMB 159,961,000 compared to RMB 95,268,000 a year ago. Profit before income tax was RMB 159,664,000 compared to RMB 94,609,000 a year ago. Profit attributable to owners of the company was RMB 132,785,000 or 23.70 cents per basic share compared to RMB 79,274,000 or 14.15 cents per basic share a year ago. The obvious growth in turnover was mainly attributable to the increase in the revenue from core revenue generator, namely Hai Kun Shen Xi capsule. The obvious growth in turnover was mainly attributable to the increase in the revenue from core revenue generator, namely Hai Kun Shen Xi capsule.

Jilin Province Huinan Changlong Bio-Pharmacy Co. Ltd. to Report Fiscal Year 2014 Results on Mar 30, 2015

Jilin Province Huinan Changlong Bio-Pharmacy Co. Ltd. announced that they will report fiscal year 2014 results on Mar 30, 2015

Jilin Province Huinan Changlong Bio-Pharmacy Co. Ltd., Board Meeting, Mar 30, 2015

Jilin Province Huinan Changlong Bio-Pharmacy Co. Ltd., Board Meeting, Mar 30, 2015., at 10:00 China Standard Time. Agenda: To consider and approve the audited consolidated financial statements for the year ended 31 December 2014 of the company and its subsidiaries, and to approve the associated draft announcement and a summary of the audited final results thereof to be published on the GEM website; to consider and approve the contents of the annual report of the company for the year of 2014; to consider the time and venue of the forthcoming annual general meeting of the company; to consider the payment of final dividend, if any; to consider the closure of the register of members, if necessary; and to transact any other business.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
8049:HK $4.38 HKD -0.07

8049 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 8049.
View Industry Companies
 

Industry Analysis

8049

Industry Average

Valuation 8049 Industry Range
Price/Earnings 14.8x
Price/Sales 3.3x
Price/Book 3.2x
Price/Cash Flow 14.8x
TEV/Sales 3.0x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact JILIN PROVINCE HUINAN-H, please visit www.jlchanglong.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.